NCT00284830

Brief Summary

SAVE PACe is a large, prospective, single-blinded, randomized clinical trial with the main objective to study the effect of unnecessary right ventricular apical pacing on the clinical outcome of time to development of persistent AF.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,070

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2003

Longer than P75 for not_applicable

Geographic Reach
2 countries

67 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2003

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

January 31, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 1, 2006

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2006

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2008

Completed
Last Updated

February 29, 2008

Status Verified

February 1, 2008

Enrollment Period

3.9 years

First QC Date

January 31, 2006

Last Update Submit

February 26, 2008

Conditions

Keywords

Right Ventricular PacingPersistent Atrial FibrillationAtrioventricular ConductionHeart Failure HospitalizationCardiovascular Health Care UtilizationSinus-node DiseaseMinimized Ventricular Pacing

Outcome Measures

Primary Outcomes (1)

  • To compare the time to development of persistent AF between all randomized subjects in the ON and OFF arms.

    from Jan 2003 to Dec 2006

Secondary Outcomes (1)

  • To compare composite endpoint of AF and heart failure hospitalization (HFH), HFH, cardiovascular health care utilization, symptoms, HF medications, cumulative %, adverse events and incidence of stroke between the arms.

    from Jan 2003 to Dec 2006

Study Arms (2)

1

ACTIVE COMPARATOR

dual-chamber minimal ventricular pacing with the use of new pacemaker features designed to promote atrioventricular conduction, preserve ventricular conduction, and prevent ventricular desynchronization

Device: Implantable Pulse Generators

2

NO INTERVENTION

conventional dual-chamber pacing

Interventions

dual-chamber minimal ventricular pacing with the use of new pacemaker features designed to promote atrioventricular conduction, preserve ventricular conduction, and prevent ventricular desynchronization

Also known as: Search AV+, Search AV, MVP, Medtronic, Dual-Chamber Pacemaker
1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age and older
  • Willing and able to give informed consent
  • Willing and able to comply with the study follow-up schedule
  • Class I/ClassII indications for dual chamber pacing
  • Initial implant of a Kappa 700, Kappa 900, EnPulse, or EnRhythm dual chamber IPG
  • Demonstrate 1 to 1 conduction and a QRS interval of \< 120ms at 100 beats per minutes for a period of nine seconds while atrial pacing

You may not qualify if:

  • Less than 18 years of age
  • Unwilling or unable to give informed consent
  • Unwilling or unable to commit to follow-up schedule
  • Medical conditions that would preclude the testing required by the protocol or limit study participation
  • Enrolled or intend to participate in another clinical trial during the course of this study
  • A life expectancy of less than 2 years
  • History of continuous atrial fibrillation for the 6 months prior to screen visit
  • Two or more cardioversions, chemical or electrical, within the past 6 months prior to screen
  • History of persistent second or third degree atrioventricular block
  • A prior implant of pacemaker or defibrillator device
  • A baseline, pre-paced QRS \>120 ms on surface ECG
  • Failure of the 1 to 1 atrioventricular conduction test
  • Anticipated major cardiac surgery within the course of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (67)

Unknown Facility

Phoenix, Arizona, United States

Location

Unknown Facility

Scottsdale, Arizona, United States

Location

Unknown Facility

Conway, Arkansas, United States

Location

Unknown Facility

Glendale, California, United States

Location

Unknown Facility

La Mesa, California, United States

Location

Unknown Facility

Santa Rosa, California, United States

Location

Unknown Facility

Boulder, Colorado, United States

Location

Unknown Facility

Denver, Colorado, United States

Location

Unknown Facility

Clearwater, Florida, United States

Location

Unknown Facility

Ft. Pierce, Florida, United States

Location

Unknown Facility

Lakeland, Florida, United States

Location

Unknown Facility

Miami Beach, Florida, United States

Location

Unknown Facility

Orlando, Florida, United States

Location

Unknown Facility

Verro Beach, Florida, United States

Location

Unknown Facility

Atlanta, Georgia, United States

Location

Unknown Facility

Tifton, Georgia, United States

Location

Unknown Facility

Maywood, Illinois, United States

Location

Unknown Facility

Rockford, Illinois, United States

Location

Unknown Facility

Lexington, Kentucky, United States

Location

Unknown Facility

Lacombe, Louisiana, United States

Location

Unknown Facility

Annapolis, Maryland, United States

Location

Unknown Facility

Salisbury, Maryland, United States

Location

Unknown Facility

Boston, Massachusetts, United States

Location

Unknown Facility

Worcester, Massachusetts, United States

Location

Unknown Facility

Ann Arbor, Michigan, United States

Location

Unknown Facility

Grand Rapids, Michigan, United States

Location

Unknown Facility

Saint Joseph, Michigan, United States

Location

Unknown Facility

Southfield, Michigan, United States

Location

Unknown Facility

Minneapolis, Minnesota, United States

Location

Unknown Facility

Saint Cloud, Minnesota, United States

Location

Unknown Facility

Saint Paul, Minnesota, United States

Location

Unknown Facility

Tupelo, Mississippi, United States

Location

Unknown Facility

St Louis, Missouri, United States

Location

Unknown Facility

Hastings, Nebraska, United States

Location

Unknown Facility

Cherry Hill, New Jersey, United States

Location

Unknown Facility

Elmer, New Jersey, United States

Location

Unknown Facility

Albuquerque, New Mexico, United States

Location

Unknown Facility

East Syracuse, New York, United States

Location

Unknown Facility

Johnson City, New York, United States

Location

Unknown Facility

New Hyde Park, New York, United States

Location

Unknown Facility

Syracuse, New York, United States

Location

Unknown Facility

The Bronx, New York, United States

Location

Unknown Facility

Charlotte, North Carolina, United States

Location

Unknown Facility

Durham, North Carolina, United States

Location

Unknown Facility

Gastonia, North Carolina, United States

Location

Unknown Facility

Bismarck, North Dakota, United States

Location

Unknown Facility

Cincinnati, Ohio, United States

Location

Unknown Facility

Kettering, Ohio, United States

Location

Unknown Facility

Mansfield, Ohio, United States

Location

Unknown Facility

Toledo, Ohio, United States

Location

Unknown Facility

Corvallis, Oregon, United States

Location

Unknown Facility

Salem, Oregon, United States

Location

Unknown Facility

Easton, Pennsylvania, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, United States

Location

Unknown Facility

York, Pennsylvania, United States

Location

Unknown Facility

Cookeville, Tennessee, United States

Location

Unknown Facility

Germantown, Tennessee, United States

Location

Unknown Facility

Nashville, Tennessee, United States

Location

Unknown Facility

Austin, Texas, United States

Location

Unknown Facility

Houston, Texas, United States

Location

Unknown Facility

Plano, Texas, United States

Location

Unknown Facility

Tyler, Texas, United States

Location

Unknown Facility

Richmond, Virginia, United States

Location

Unknown Facility

Vancouver, British Columbia, Canada

Location

Unknown Facility

Winnipeg, Manitoba, Canada

Location

Unknown Facility

Sainte-Foy, Quebec, Canada

Location

Unknown Facility

Trois-Rivières, Quebec, Canada

Location

Related Publications (1)

  • Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D, Sheldon T, Lamas GA; Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med. 2007 Sep 6;357(10):1000-8. doi: 10.1056/NEJMoa071880.

MeSH Terms

Conditions

Sick Sinus SyndromeHeart FailureAtrial FibrillationBradycardiaVentricular Dysfunction

Condition Hierarchy (Ancestors)

Arrhythmia, SinusArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesHeart BlockCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michael O. Sweeney, MD

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

January 31, 2006

First Posted

February 1, 2006

Study Start

January 1, 2003

Primary Completion

December 1, 2006

Study Completion

February 1, 2008

Last Updated

February 29, 2008

Record last verified: 2008-02

Locations